About the company
Laccure AB was founded in 2007 and is a project company within the group of the Swedish life science company AQILION AB. Both companies are privately owned and based in Helsingborg, Sweden. Aqilion scouts and unlocks life science potential.
To learn more, please visit:
Company highlights
2007: Patent application for the use of the substance for treatment and prevention of gynecological infections
2010: GMP manufacturing for clinical trials completed
2011: Preclinical study results showed no vaginal irritation
2011: Completion of international survey in 2,660 women in the U.S, the U.K. and Germany
2012: Patent application for the protection of the formulation and manufacturing of Laccure’s product
2012: Completion of the upscaled commercial manufacturing of the substance to be used in Laccure’s vaginal pessary
2012: Completion of clinical trials with excellent results
2014: Final completion of preclinical study package. Results showed no cytotoxicity, sensitization or vaginal irritation
2015: Excellent clinical data on Laccure’s vaginal pessary were presented at XXI FIGO World Congress on Gyn & Obstetrics in Vancouver, Canada
2015: Laccure announced that its antibiotic-free consumer health product for bacterial vaginosis was ready for commercialization
2016: Laccure AB entered into a collaboration with Recipharm AB, a Swedish global leading contract development and manufacturing organization, for the commercial manufacturing and delivery of Laccure® pessary
2017: Laccure AB and Combe Inc. signed an exclusive global license agreement to Laccure’s new female consumer health product for treatment of bacterial vaginosis
2019: Combe Inc., announced the termination of the license agreement with Laccure AB since Combe changed its priorities and strategy for its development projects. Laccure took the product back and continued to pursue development toward commercialization with support from AQILION AB, one of the major owners and co-founder of Laccure
2019: Decision to test a new manufacturing method with the aim to receive a robust method resulting in more attractive costs
2020: Successful completion of small-scale manufacturing method
Laccure AB
Corporate Identity Number 556725-2076
Contact
E-mail: info@aqilion.com
By contacting us, you accept our privacy policy.
Visiting and postal address
Kullagatan 8, SE-252 20 Helsingborg, Sweden